KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
75 hedge funds and large institutions have $233M invested in Kindred Biosciences, Inc. in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
75
Holding in Top 10
1
Calls
$437K
Puts
–
Top Buyers
| 1 | +$7.26M | |
| 2 | +$6.8M | |
| 3 | +$5.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.64M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.76M |
Top Sellers
| 1 | -$6.3M | |
| 2 | -$1.63M | |
| 3 | -$1.08M | |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.06M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.05M |